Viewing StudyNCT00316693



Ignite Creation Date: 2024-05-05 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00316693
Status: COMPLETED
Last Update Posted: 2018-09-04
First Post: 2006-04-19

Brief Title: Human Papillomavirus HPV Vaccine Cervarix TM Efficacy Immunogenicity Safety Trial in Adult Japanese Women With GSK Biologicals HPV-1618 Vaccine
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-04-26
Start Date Type: None
Primary Completion Date: 2009-02-10
Primary Completion Date Type: ACTUAL
Completion Date: 2009-02-10
Completion Date Type: ACTUAL
First Submit Date: 2006-04-19
First Submit QC Date: April 19 2006
Study First Post Date: 2006-04-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2009-12-16
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-08-30
Last Update Post Date: 2018-09-04
Last Update Post Date Type: ACTUAL